270 related articles for article (PubMed ID: 33208147)
1. Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
Nachmanson D; Steward J; Yao H; Officer A; Jeong E; O'Keefe TJ; Hasteh F; Jepsen K; Hirst GL; Esserman LJ; Borowsky AD; Harismendy O
BMC Med Genomics; 2020 Nov; 13(1):173. PubMed ID: 33208147
[TBL] [Abstract][Full Text] [Related]
2. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
Hartmann K; Schlombs K; Laible M; Gürtler C; Schmidt M; Sahin U; Lehr HA
Diagn Pathol; 2018 Oct; 13(1):83. PubMed ID: 30342538
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.
Bhagwate AV; Liu Y; Winham SJ; McDonough SJ; Stallings-Mann ML; Heinzen EP; Davila JI; Vierkant RA; Hoskin TL; Frost M; Carter JM; Radisky DC; Cunningham JM; Degnim AC; Wang C
BMC Genomics; 2019 Sep; 20(1):689. PubMed ID: 31477010
[TBL] [Abstract][Full Text] [Related]
4. Integrative molecular profiling of routine clinical prostate cancer specimens.
Grasso CS; Cani AK; Hovelson DH; Quist MJ; Douville NJ; Yadati V; Amin AM; Nelson PS; Betz BL; Liu CJ; Knudsen KE; Cooney KA; Feng FY; McDaniel AS; Tomlins SA
Ann Oncol; 2015 Jun; 26(6):1110-1118. PubMed ID: 25735316
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.
Loudig O; Wang T; Ye K; Lin J; Wang Y; Ramnauth A; Liu C; Stark A; Chitale D; Greenlee R; Multerer D; Honda S; Daida Y; Spencer Feigelson H; Glass A; Couch FJ; Rohan T; Ben-Dov IZ
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335433
[TBL] [Abstract][Full Text] [Related]
6. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
[TBL] [Abstract][Full Text] [Related]
7. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
8. Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
Pang JB; Savas P; Fellowes AP; Mir Arnau G; Kader T; Vedururu R; Hewitt C; Takano EA; Byrne DJ; Choong DY; Millar EK; Lee CS; O'Toole SA; Lakhani SR; Cummings MC; Mann GB; Campbell IG; Dobrovic A; Loi S; Gorringe KL; Fox SB
Mod Pathol; 2017 Jul; 30(7):952-963. PubMed ID: 28338653
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples.
Martelotto LG; Baslan T; Kendall J; Geyer FC; Burke KA; Spraggon L; Piscuoglio S; Chadalavada K; Nanjangud G; Ng CK; Moody P; D'Italia S; Rodgers L; Cox H; da Cruz Paula A; Stepansky A; Schizas M; Wen HY; King TA; Norton L; Weigelt B; Hicks JB; Reis-Filho JS
Nat Med; 2017 Mar; 23(3):376-385. PubMed ID: 28165479
[TBL] [Abstract][Full Text] [Related]
10. Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA.
Stiller M; Sucker A; Griewank K; Aust D; Baretton GB; Schadendorf D; Horn S
Oncotarget; 2016 Sep; 7(37):59115-59128. PubMed ID: 27463017
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
12. Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores.
Schobesberger M; Baltzer A; Oberli A; Kappeler A; Gugger M; Burger H; Jaggi R
BMC Cancer; 2008 Nov; 8():343. PubMed ID: 19032762
[TBL] [Abstract][Full Text] [Related]
13. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
14. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
[TBL] [Abstract][Full Text] [Related]
15. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Pang JM; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB
Breast Cancer Res; 2014 Oct; 16(5):423. PubMed ID: 25331261
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
de Schaetzen van Brienen L; Larmuseau M; Van der Eecken K; De Ryck F; Robbe P; Schuh A; Fostier J; Ost P; Marchal K
BMC Med Genomics; 2020 Jul; 13(1):94. PubMed ID: 32631411
[TBL] [Abstract][Full Text] [Related]
17. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
18. FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.
Wilkins A; Chauhan R; Rust A; Pearson A; Daley F; Manodoro F; Fenwick K; Bliss J; Yarnold J; Somaiah N
Breast Cancer Res Treat; 2018 Aug; 170(3):573-581. PubMed ID: 29700676
[TBL] [Abstract][Full Text] [Related]
19. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
20. Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
Bonnet E; Moutet ML; Baulard C; Bacq-Daian D; Sandron F; Mesrob L; Fin B; Delépine M; Palomares MA; Jubin C; Blanché H; Meyer V; Boland A; Olaso R; Deleuze JF
PLoS One; 2018; 13(4):e0195471. PubMed ID: 29621323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
